OrganiGram Holdings (OGI) Gets a Hold Rating from Oppenheimer

In a report released today, Rupesh Parikh from Oppenheimer maintained a Hold rating on OrganiGram Holdings (OGIResearch Report). The company’s shares closed last Tuesday at $3.08.

According to, Parikh is a 5-star analyst with an average return of 12.1% and a 65.2% success rate. Parikh covers the Consumer Goods sector, focusing on stocks such as Bj’s Wholesale Club Holdings, The Estée Lauder Companies, and Albertsons Companies.

The word on The Street in general, suggests a Hold analyst consensus rating for OrganiGram Holdings with a $3.65 average price target, representing a 17.4% upside. In a report issued on June 11, CIBC also maintained a Hold rating on the stock with a C$3.75 price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $6.45 and a one-year low of $1.01. Currently, OrganiGram Holdings has an average volume of 9.4M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. Its products include strains, cannabis oils, and vaporizrs. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.